Is Rep 529 real-time PCR suitable for diagnosis of toxoplasmosis in patients infected with non-type II strains in Northern America?
Toxoplasma gondii DNA detection is essential to diagnose antenatally a congenital infection and reactivation of a past infection in an immunocompromised patient. First PCR methods targeted the 35-fold repetitive B1 gene and more recently, coding sequence Rep 529 was preferred as it was described to be 200 to 300-fold repeated and yielded a far better sensitivity than the amplification of B1 sequence. To date, few data are available when considering efficacy of Rep 529 for non-type II genotypes. In this study, we compared the results of B1 qPCR with two different Rep 529 qPCRs performed on 111 samples in two different laboratories (Rep 529-1 and Rep 529-2). Performances of the 3 qPCRs were also compared according to the genotype of the isolates for 13 type II and 21 non-type II samples. Performance of the Rep 529 target was superior to that of the B1 target regardless of the genotype (CT values for Rep 529-1 and Rep 529-2 qPCRs were lower than B1 qPCR; p<0.001 and p<0.01 respectively). Same results were observed when a comparison was made according to the genotype of the strain: for type II and for non-type II genotype. These results provide, to our knowledge, first relative quantitative data, revealing that efficiency of Rep 529 does not depend on the genotype of the T. gondii isolates and that, in fact, it is superior to B1.